LogoReframe Daily
Login
Solve healthcare overwhelm
LogoReframe Daily

Archive

Reframe Daily: Fish oil helps burn patients heal faster, new probiotic spray eases BV, and mice beat type 1 diabetes

Nov 18, 2025

•

3 min read

Reframe Daily: Fish oil helps burn patients heal faster, new probiotic spray eases BV, and mice beat type 1 diabetes

A small trial found fish oil calmed inflammation and steadied blood sugar in people with serious burns; a clinic program for first-episode psychosis sharply cut the risk of later schizophrenia; a vaginal probiotic spray improved symptoms of bacterial vaginosis; a combo of tumor “microwave” ablation plus dual immunotherapy showed promise for tough pancreatic cancer; and an antibody-based transplant approach completely reversed type 1 diabetes in mice without long-term chemo drugs.

Christin Chong, PhD
Christin Chong, PhD
Reframe Daily: New heart valve, kidney-saving combo pill, and a stool test that reads your gut

Nov 17, 2025

•

4 min read

Reframe Daily: New heart valve, kidney-saving combo pill, and a stool test that reads your gut

Today’s research drop: a catheter-placed heart valve that helps people too fragile for open-heart surgery, a new pill combo that cut kidney-damaging protein in urine, and a stool test that can read your gut’s immune cells one by one—plus two early-stage ways to protect hearts and aging guts in the future.

Christin Chong, PhD
Christin Chong, PhD
Reframe Daily: New nerve treatment for stubborn blood pressure, plus DNA clues for thyroid disease and sharper cancer surgery

Nov 14, 2025

•

3 min read

Reframe Daily: New nerve treatment for stubborn blood pressure, plus DNA clues for thyroid disease and sharper cancer surgery

Today’s health news brings a nerve treatment that lowered blood pressure in hard-to-treat patients, a DNA risk score that flags people likely to get thyroid disease, a lab test that spots hidden lung germs, a better way to see cancer edges in surgery, and a new brain “zinc switch” that could guide future nerve-protecting drugs.

Christin Chong, PhD
Christin Chong, PhD
Reframe Daily: Iron + fiber for kids with HIV, pig kidney progress, and a gut fungus that calms colitis

Nov 13, 2025

•

4 min read

Reframe Daily: Iron + fiber for kids with HIV, pig kidney progress, and a gut fungus that calms colitis

Today’s studies show a simple iron-and-fiber mix making treatment easier for children with HIV, a gene-edited pig kidney working in a human body for weeks, and a gut fungus plus new cell “switches” that could someday ease colitis, diabetes, and cancer.

Christin Chong, PhD
Christin Chong, PhD
Reframe Daily: Nose spray for faster healing and a nasal HPV cancer vaccine in the lab

Nov 12, 2025

•

4 min read

Reframe Daily: Nose spray for faster healing and a nasal HPV cancer vaccine in the lab

Scientists tested a love-hormone nose spray, pre-surgery “training,” sound-wave brain openings, gene fixes for hearing loss, and a nasal HPV cancer vaccine—each pushing healing and cancer control forward in new ways.

Christin Chong, PhD
Christin Chong, PhD
Reframe Daily: Hot flashes eased without pills; tumor-zapping helps; new shield for implant infections

Nov 11, 2025

•

3 min read

Reframe Daily: Hot flashes eased without pills; tumor-zapping helps; new shield for implant infections

Self-guided hypnosis cooled hot flashes; ablation + immunotherapy held lung cancer longer; a lab “scaffold” shot blocked implant staph—plus spleen-targeting nanoparticles and a safer oral immune booster.

Christin Chong, PhD
Christin Chong, PhD
Reframe Daily: Shot helps prevent first heart attacks; one-time gene edit lowers bad fats

Nov 10, 2025

•

3 min read

Reframe Daily: Shot helps prevent first heart attacks; one-time gene edit lowers bad fats

Plus: a new kidney antibody cut protein in urine, a monthly shot lowered very high triglycerides, and a two-drug combo weakened hepatitis D in patients.

Christin Chong, PhD
Christin Chong, PhD
Reframe Daily: Dialysis plan speeds kidney recovery; early Hep B cure sign; mRNA shots last longer

Nov 7, 2025

•

3 min read

Reframe Daily: Dialysis plan speeds kidney recovery; early Hep B cure sign; mRNA shots last longer

An ICU study used fewer dialysis sessions and got more kidneys working again; a mid-stage trial found an RNA add-on helped more people clear signs of hepatitis B; new delivery and chemistry could make flu mRNA shots work better and last longer; and one simple test reads proteins and genes from the same sample.

Christin Chong, PhD
Christin Chong, PhD
Reframe Daily: Psoriasis pill rivals shots; allergy med relieves ER vertigo fast; some can skip breast-cancer radiation

Nov 6, 2025

•

3 min read

Reframe Daily: Psoriasis pill rivals shots; allergy med relieves ER vertigo fast; some can skip breast-cancer radiation

Plus: a targeted kidney drug slowed IgA damage that can lead to dialysis, and a nose-spray H5N1 flu vaccine showed strong, broad immunity in an early human study.

Christin Chong, PhD
Christin Chong, PhD
Reframe Daily: Many after mastectomy can skip radiation; antibody cuts kidney relapses; psoriasis pill works

Nov 5, 2025

•

3 min read

Reframe Daily: Many after mastectomy can skip radiation; antibody cuts kidney relapses; psoriasis pill works

A 10-year trial shows many women who had a mastectomy can safely skip chest-wall radiation. An antibody drug kept tough kidney disease from coming back, an oral IL-23 blocker eased psoriasis, a one-shot Lassa vaccine looked safe in people, and a “teach-the-immune-system” shot for knee arthritis did what doctors hoped in early testing.

Christin Chong, PhD
Christin Chong, PhD
Reframe Daily: 2-month HIV shots match daily pills for 2 years; AR helps nerve-tumor surgery

Nov 4, 2025

•

4 min read

Reframe Daily: 2-month HIV shots match daily pills for 2 years; AR helps nerve-tumor surgery

Plus: a rare gene change in esophagus cancer responded to a newer cancer pill; a new RNA tool fixed gene messages and cut cholesterol in mice; and dialing down a liver-scar switch slowed fibrosis.

Christin Chong, PhD
Christin Chong, PhD
Reframe Daily: Diabetes drug cuts stroke risk; new COVID blocker and mosquito virus antibody show promise

Nov 3, 2025

•

4 min read

Reframe Daily: Diabetes drug cuts stroke risk; new COVID blocker and mosquito virus antibody show promise

A stroke-prevention win from an existing diabetes drug, a coronavirus enzyme blocker that stopped COVID in mice, and antibodies that neutralize chikungunya virus—all point to faster paths from lab to clinic.

Christin Chong, PhD
Christin Chong, PhD
1...1112131415...21
Reframe Daily

Reframe Daily

Good News in AI + Healthcare. We summarize top credible headlines and send you a roundup each day!


Home

Posts

© 2026 reframescience.org.
beehiivPowered by beehiiv